MS Connect
  • Saved
Crisis readiness for rare disease populations: learnings and recommendations by the European Reference Networks. - PubMed

Crisis readiness for rare disease populations: learnings and recommendations by the European Reference Networks. - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/42604059

A survey reveals limited crisis preparedness in rare disease care during COVID-19 and Ukraine war. Solutions include enhanced cross-border coordination.


Only 8.3% of European Reference Networks had crisis plans for COVID-19 and Ukraine war. Highlight integration into health emergency mechanisms.

  • Saved
Stage-Dependent Physiotherapy for Recovery From Supplementary Motor Area Syndrome: A Case Report. - PubMed

Stage-Dependent Physiotherapy for Recovery From Supplementary Motor Area Syndrome: A Case Report. - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/42568685

Discover the role of nursing care in facilitating recovery through stage-dependent rehabilitation for SMA syndrome post-tumor resection.


Nursing care and tailored rehabilitation improved motor function in SMA syndrome post-surgery, emphasizing coordinated tasks aligned with recovery stages.

  • Saved

Did you know?

The Tysabri Observational Program (TOP) — a multinational real-world registry of 6,319 patients with relapsing-remitting MS — has now completed 15 years of prospective follow-up, making it one of the longest continuous observational datasets in multiple sclerosis. The final analysis confirmed that annualized relapse rate reductions were sustained across all 15 years, no new safety signals emerged, and patients who remained on this selective α4-integrin blocker showed a significantly lower probability of converting to non-active secondary progressive MS vs. those who discontinued.

NCCN Guidelines
Discussion question

With 15 years of real-world data now available, how does long-term evidence on disability trajectory and SPMS conversion influence your discussions with RRMS patients considering high-efficacy therapy for the first time?

  • Saved
Recent Advances in AS101 and Tellurium-Based Nanoplatforms for Immunomodulation, Cancer Therapy, Antimicrobial Activity, and Toxicological Assessment. - PubMed

Recent Advances in AS101 and Tellurium-Based Nanoplatforms for Immunomodulation, Cancer Therapy, Antimicrobial Activity, and Toxicological Assessment. - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/42540262

AS101 and TeNPs offer immunomodulatory and antimicrobial potential. Further research is needed for safety in therapies, relevant for nursing professionals in patient care.


AS101 and TeNPs modulate cytokine signaling, inhibit integrins, and show antimicrobial effects. Further studies needed for safety in photothermal therapy and anticancer applications.

  • Saved
Comparative validation of LC-MS, micro-bioassay, and ELISA for lincomycin quantification: application to pharmacokinetic analysis in healthy and co-infected porcine models. - PubMed

Comparative validation of LC-MS, micro-bioassay, and ELISA for lincomycin quantification: application to pharmacokinetic analysis in healthy and co-infected porcine models. - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/42500957

Study validates LC-MS, MBa, and ELISA for lincomycin quantification in swine, informing nursing practices for effective dose optimization in managing co-infections.


LC-MS, MBa, and ELISA yield comparable pharmacokinetic data for lincomycin in healthy and co-infected swine, informing nursing practices in managing co-infections.